Smart syringes are important to promote safe healthcare systems. Smart syringes are increasingly gaining popularity as the number of blood-borne infections are increasing due to unsafe injections especially in low-income, developing countries. Smart syringes have features that prevent its re-use. There are many types of syringes, they can break if the user tries to pull back on the plunger after its use. Other types have metal clips that block the plunger from moving back and in yet others the needle retracts into the syringe barrel after its administration.
World Health Organization (WHO), in 2015 issued guidelines recommending safe use of injections and transition to safety engineered injection devices for all kinds of injections by 2020. Owing to the ongoing Covid-19 pandemic it is expected that the global demand for syringes for COVID-19 vaccinations alone is expected between 8-10 billion. In the previous years, only 5% to 10% of the estimated 16 billion syringes used worldwide were meant for vaccination and immunization.
Based on product the market is segmented into active safety syringes, passive safety syringes and auto disable syringes. Auto Disable syringes get automatically blocked after their single use and thus cannot be reused.
Based on application the market is segmented into drug delivery, vaccination, and blood specimen collection.The segments dominance is due to its extensive use for injecting medicines to the diabetes patients. In 2019, more than 463 million adults (aged 20-79 years) were living with diabetes, the number is expected to rise to 700 million by 2045. Among which 79% of adults with diabetes condition live in low and middle-income countries.
Based on end-user the market is segmented into hospitals and clinics, homecare, and others. Hospitals and clinics segment dominates the use of smart syringes. With the help of WHO and UNICEF smart syringes are becoming more and more common in the hospitals. However, due to their high price, they are less prevalent in the low-income countries.
For a better understanding of the market and overall adoption and availability of smart syringes, the report provides detailed analysis for major regions including North America (US, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. However, the Asia Pacific is expected to witness highest CAGR growth during the forecast period.
Some of the major players operating in the market include Retractable Technologies, Inc., AdvaCare Pharma, Numedico Technologies Pty Ltd, Gerresheimer AG, Parker Hannifin Corp, Cardinal Health, Terumo Corporation, Baxter, Braun Melungeon AG and Becton, Dickinson, and company. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions.
TABLE OF CONTENTS
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Smart Syringe Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Smart Syringe Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 COVID-19 IMPACT
6 MARKET INSIGHTS BY PRODUCT
6.1 Active Safety Syringes
6.2 Passive Safety Syringes
6.3 Auto Disable Syringes
7 MARKET INSIGHTS BY APPLICATION
7.1 Drug Delivery
7.3 Blood Specimen Collection
8 MARKET INSIGHTS BY END-USER
8.1 Hospitals and Clinics
9 MARKET INSIGHTS BY REGION
9.1 NORTH AMERICA SMART SYRINGE MARKET
9.2 EUROPE SMART SYRINGE MARKET
9.3 ASIA-PACIFIC SMART SYRINGE MARKET
9.4 REST OF THE WORLD SMART SYRINGE MARKET
10 LEGAL AND REGULATORY FRAMEWORK
11 DEMAND AND SUPPLY SIDE ANALYSIS
11.1 Demand Side Analysis
11.2 Supply Side Analysis
+44 203 500 2763
+1 62 825 80070
Note: The Heraldkeeper News Department was not involved in the creation of this content.
If you have any problem with this press release? Contact the source provider Heraldkeeper.com, you can contact them here.